Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Self · Elevance Health, Inc. · Elevance Health, Inc. Common Stock
Purchase
Disclosed range starting at $1K
Disclosed 116 days after execution (STOCK Act deadline: 45)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Lavu RatnakarEVP & Chief Digital Info Ofr | Open-market sale | SELL | $572K 1,300 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 32 | Kaye MarkEVP & CFO | Open-market sale | SELL | $510K 1,160 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 29 | Kaye MarkEVP & CFO | Open-market sale | SELL | $140K 321 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 29 | Kaye MarkEVP & CFO | Open-market sale | SELL | $245K 560 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 36 | Kaye MarkEVP & CFO | Open-market sale | SELL | $758K 1,720 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 39 | Kaye MarkEVP & CFO | Open-market sale | SELL | $1.03M 2,343 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 29 | Kaye MarkEVP & CFO | Open-market sale | SELL | $105K 240 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 29 | Kaye MarkEVP & CFO | Open-market sale | SELL | $212K 480 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 29 | Kaye MarkEVP & CFO | Open-market sale | SELL | $174K 400 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 36 | Kaye MarkEVP & CFO | Open-market sale | SELL | $724K 1,660 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 32 | Kaye MarkEVP & CFO | Open-market sale | SELL | $369K 827 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 29 | Kaye MarkEVP & CFO | Open-market sale | SELL | $122K 273 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 29 | Kaye MarkEVP & CFO | Open-market sale | SELL | $71K 160 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 29 | Kaye MarkEVP & CFO | Open-market sale | SELL | $195K 440 sh | Oct 23, 2026 traded Oct 22, 2026 | |
| 13 | Kaye MarkEVP & CFO | Grant or award | A | — 2,627 sh | Oct 6, 2026 traded Oct 2, 2026 | |
| 22 | Kaye MarkEVP & CFO | Tax withholding | F | $1.61M 4,161 sh | Oct 6, 2026 traded Oct 2, 2026 | |
| 12 | Craig Ryan REVP & Chief HR Officer | Tax withholding | F | $58K 144 sh | Sep 4, 2026 traded Sep 2, 2026 | |
| 12 | Wessling Erin MEVP & Chief Legal Officer | Tax withholding | F | $106K 255 sh | Sep 4, 2026 traded Sep 3, 2026 | |
| 9 | Wessling Erin MEVP & Chief Legal Officer | Tax withholding | F | $38K 94 sh | Sep 4, 2026 traded Sep 2, 2026 | |
| 9 | Wessling Erin MEVP & Chief Legal Officer | Grant or award | A | — 11.8K sh | Mar 4, 2026 traded Mar 2, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Midpoint = (low + high) / 2. Used only to rank and sum ranges; the true value can be anywhere in the range.
= $8,001
Alan Armstrong reported a purchase of Elevance Health, Inc. Common Stock. Members report a value range, not an exact amount, and do not report share counts or prices. Dates are as entered by the filer. A trade report is not evidence of wrongdoing.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.
Recorded votes from the House Clerk and Voteview (Senate). Listed by date; a vote near a trade is not evidence the two are related.